ARCHIVES

NCI Program Develops Bioinformatics Tool To Design Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 28 No. 33 | September 13, 2002

Download PDF Visit The Full Archive

Related Articles

State Cancer Incidence Report Published by NCI, CDC

November 22, 2002

Arzerra Maintenance Therapy Extends PFS In Phase III Trial, Compared to Observation

August 29, 2014

ACS Concludes That Laetrile Organization Is Insignificant

November 29, 1991

Second-Generation CML Drugs Show Promise For Frontline

December 26, 2008

Letter to the Editor: A Victory for Research, But Real Work Is Ahead

November 26, 1999

In Brief: Broder to Discuss Centers Plan Between Meeting; Symposium Depicted To William Scott

May 11, 1990